Articles from International Myeloma Foundation

STUDIO CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members and longtime philanthropist John O’Dwyer, who lived with myeloma for 18 years until he peacefully passed this Sunday, April 27, surrounded by family and friends. 

STUDIO CITY, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members and longtime philanthropist John O’Dwyer, who lived with myeloma for 18 years until he peacefully passed this Sunday, April 27, surrounded by family and friends.

Myeloma Action Month Global Campaign Celebrates Resilience, Strengthens Connections, and Inspires Hope in 52 Countries Worldwide 

Aims to raise vital funding for the iStopMM Project and Other IMF Research Initiatives

STUDIO CITY, Calif., March 01, 2025 (GLOBE NEWSWIRE) -- Myeloma Action Month is an annual global awareness campaign that takes place every March to raise awareness and inspire action for multiple myeloma—a blood cancer that affects over 176,404 people every year, around the world.

STUDIO CITY, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) announced today that Mr. Yelak Biru has decided to step down as President & CEO. Mr. Biru’s last day with the organization will be on February 28, 2025. 

Extends Gratitude to Outgoing Board Members for Their Years of Dedicated Service to the IMF Board

International Myeloma Foundation (IMF) to hold AMN Awards Ceremony at the 8th AMN Summit in Seoul, South Korea on Saturday, October 19

SparkCures’ best-in-class clinical trial matching and navigation service is now accessible via myeloma.org.

The inaugural IMF Latin American Myeloma Network Summit will take place on Saturday, September 28, after the International Myeloma Society (IMS) Meeting in Rio De Janeiro, Brazil

Partners with ZS Associates and AWS to Develop Groundbreaking First-of-its-kind Gen AI Companion

LOS ANGELES, Aug. 29, 2024 (GLOBE NEWSWIRE) -- With Blood Cancer Awareness Month coming up this September, the International Myeloma Foundation (IMF) is reviving and amplifying its highly successful #kNOwMyeloma campaign, centering on the question: "Do You Know Myeloma?"

NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF), in partnership with the National Medical Association (NMA), the W. Montague Cobb Institute, and the Student National Medical Association (SNMA), sent a delegation of twelve IMF Medical Student Scholars for Health Equity in Myeloma along with their mentors to the 2024 NMA Annual Convention and Scientific Assembly, which took place in New York City, NY from August 3-7, 2024.

STUDIO CITY, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members, Myeloma Support Group Leader Jack Aiello, who lived with myeloma for 29 years until he peacefully passed this Saturday, July 13, surrounded by family and friends.

Assembles Global Dream Team and Establishes Scientific Advisory Board to Accelerate Myeloma Research

The Successful Briefing Addressed Insurance Coverage for Oral Anticancer Medications

Awarding ceremonies to be held on June 11 at the 15th Annual IMWG Summit in Madrid, Spain

With Over $675,000 Raised, the Gala Benefits the Peter Boyle Research Fund and Celebrates Groundbreaking Myeloma Research, Education, Support, and Advocacy

This conclusion is the result of almost 10 years of research carried out by the International Myeloma Foundation

STUDIO CITY, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and Black Swan Research Initiative® (BSRI) announced the recently published cohort study by the iStopMM (Iceland Screens, Treats, or Prevents Multiple Myeloma) team on the “Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons with Monoclonal Gammopathy of Undetermined Significance (MGUS): A Cohort Study Nested in a Clinical Trial.” The study was published in the Annals of Internal Medicine on April 2.

2024 Myeloma Action Month Global Campaign Brings Wave of Myeloma Awareness to 36 Countries Worldwide

STUDIO CITY, Calif. , March 14, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is thrilled to welcome lifelong philanthropist and 17-year myeloma survivor John O’Dwyer to the IMF Board.

Partnering with GMAN, Global Campaign Focuses on Raising Awareness and Taking Action for Myeloma to Bring Hope to Patients and Care Partners

STUDIO CITY, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is excited to announce the launch of the Iceland Cycling Expedition (ICE)—a 3-day, 2-night fundraiser biking tour set to take place from August 29 - September 4, 2024, in Reykjavik and around Iceland to kick off Blood Cancer Awareness Month, which happens every September.

LOS ANGELES, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation has recently announced the appointment of Dr. Poornima Parameswaran, the Chief Executive Officer, and Co-founder of Trace Genomics, to its board. Poornima is a three-year myeloma warrior. This appointment underscores IMF's ongoing commitment to bridge cutting-edge science and innovation with an entrepreneurial mindset and patient-centered advocacy in the fight against myeloma.

STUDIO CITY, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) formally welcomed world-renowned myeloma clinician and researcher S. Vincent Rajkumar, MD as the foundation’s new Chairperson of the Board on Friday, February 2.

STUDIO CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Working alongside the International Myeloma Foundation (IMF), American songwriter, actor, producer, and well-known artist Ice-T is on a mission to help raise awareness of multiple myeloma in the African American community.

STUDIO CITY, Calif., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members, Clinical Professor of Medicine and Medical Oncology, Director of the Center to Eliminate Cancer Disparities at Sidney Kimmel Cancer Center at Jefferson, and 116th President of the National Medical Association Edith Peterson Mitchell, MD, MACP, FCPP, FRCP (London).

iStopMM team members Thorir Einarsson Long, Jon Thorir Oskarsson, and Sæmundur Rognvaldsson are 2023 ASH Abstract Achievement Awardees

WASHINGTON, Nov. 08, 2023 (GLOBE NEWSWIRE) -- In a significant stride toward ensuring equitable access to cancer treatments, Members of the House of Representatives reintroduced the Cancer Drug Parity Act today. The bill has garnered widespread endorsement from prominent healthcare organizations and patient advocacy groups.

Leading Myeloma Organization Improving Health Equity for All

International Myeloma Foundation (IMF) to hold first-ever AMN Awards Ceremony at the 7th AMN Summit in Bangkok, Thailand on October 21

NEW ORLEANS, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF), in partnership with the National Medical Association (NMA), the W. Montague Cobb Institute, and the Student National Medical Association (SNMA), sent a delegation of eleven IMF Medical Student Scholars for Health Equity in Myeloma along with their mentors to the 2023 NMA Annual Convention and Scientific Assembly, which took place in New Orleans, LA from July 29-August 2, 2023.

LOS ANGELES, Aug. 31, 2023 (GLOBE NEWSWIRE) --  The International Myeloma Foundation (IMF) announced today that global leader and patient advocate Emma Hatcher has been named as the IMF’s Global Vice President of Patient Engagement & Advocacy. This hire is one of many strategic investments IMF has committed to in pursuit of centering the needs and voices of the myeloma community in all its work.

LOS ANGELES, Aug. 24, 2023 (GLOBE NEWSWIRE) -- In 2010, the U.S. Congress designated September as Blood Cancer Awareness Month to create awareness, increase fundraising, and support patients affected by all types of blood cancers.  

LOS ANGELES, July 27, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today welcomed two of its newest Board Members: Myeloma Support Group Leader and 28-year myeloma survivor Jack Aiello, and Global Finance and Strategy Leader and 2-year myeloma survivor Sanjay Singh.

Current Chairman of the Board of Directors Brian G.M. Durie, MD will not seek re-election for 2024 term

LOS ANGELES, July 13, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that a 2023 IMF Patient and Family Seminar (PFS) will take place in-person from August 18-19 at the Sofitel Los Angeles at Beverly Hills on 8555 Beverly Blvd., Los Angeles, CA 90048. For those who are unable to attend, there will be a livestream of the seminar for remote viewing.

A Comprehensive Online Educational Program on Multiple Myeloma

Bipartisan legislation will bring equality to insurance coverage of life-saving medicines

LOS ANGELES, June 01, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is proud to announce the recipients of this year’s Robert A. Kyle Achievement Award and Brian G.M. Durie Outstanding Achievement Award. The in-person awards ceremony will be held on June 8, Thursday at the 14th Annual International Myeloma Working Group (IMWG) Summit in Frankfurt, Germany.

LOS ANGELES, May 25, 2023 (GLOBE NEWSWIRE) -- Founded in 2013 by the International Myeloma Foundation (IMF), the Global Myeloma Action Network (GMAN) will hold its Annual Summit in Frankfurt Germany, from June 2-4, 2023.

LOS ANGELES, May 18, 2023 (GLOBE NEWSWIRE) -- Diagnosed in 2008 at age 59 with multiple myeloma, Andy Sninsky continues to be a formidable inertia in motion and a perpetual source of inspiration for the International Myeloma Foundation (IMF) and the myeloma community at large.

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

STUDIO CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) has partnered with the W. Montague Cobb/NMA Health Institute’s Cobb Scholars Program to develop a mentoring program for African American medical school students.

The International Myeloma Foundation Reached Over 41 Million in More Than 45 Countries During 2023 Myeloma Action Month!

PHILADELPHIA, April 03, 2023 (GLOBE NEWSWIRE) -- The Annual Miles for Myeloma Hybrid 5K Run/Walk will once again “Redefine Being Together” on Saturday, April 29, virtually and in-person at FDR Park in Philadelphia, PA — with the common goal of finding a cure for multiple myeloma.

STUDIO CITY, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- With the International Myeloma Foundation (IMF) at the forefront, Myeloma Action Month is held every year for the whole month of March to encourage individuals and groups to take actions that positively impact the myeloma community. This year the IMF invites YOU to take the action of storytelling.

BOCA RATON, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that this year’s first Patient and Family Seminar is taking place in-person and virtually on March 17–18, 2023, in Boca Raton, Florida. The event will serve to help patients and their families learn from world-renowned myeloma experts face-to-face while bonding with others in the community. The Boca Raton, Florida, seminar marks the start of the IMF’s return to in-person patient events after a 3-year hiatus due to the COVID-19 pandemic.

The International Myeloma Foundation will work with Amazon’s cloud computing arm to educate patients, understand donors, increase fundraising, and more

FORT DETRICK, Md., Nov. 03, 2022 (GLOBE NEWSWIRE) -- The Congressionally Directed Medical Research Programs’ (CDMRP), Peer Reviewed Cancer Research Program (PRCRP) consumer advocate recently participated in the evaluation of research applications submitted to the PRCRP. Paul Gater was nominated for participation in the program by The International Myeloma Foundation (IMF), Los Angeles, CA. As a consumer reviewer, Paul was a full voting member, (along with prominent scientists) at meetings to help determine how the $130 million appropriated by Congress for Fiscal Year 2022 will be spent on peer reviewed cancer research.

STUDIO CITY, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced the details of the recent fundraising celebration hosted by Fatima Scipione and her husband, Jimmy Scipione.

CLARK, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) -- The Annual Miracles for Myeloma 5K Hybrid Run/Walk will be celebrating its tenth anniversary this year. For the past nine years, this annual event has raised over $700,000 and has funded eight Brian D. Novis (BDN) Research Grants.